Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

ShunJiang Yu

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Molecular Endocrinology (Baltimore, Md.)|May 1, 2002
Fibroblast growth factor receptor 4 is a target for the zinc-finger transcription factor Ikaros in the pituitaryShunJiang Yu, Sylvia L Asa, Shereen Ezzat
Molecular Endocrinology (Baltimore, Md.)|December 25, 2004
The zinc finger Ikaros transcription factor regulates pituitary growth hormone and prolactin gene expression through distinct effects on chromatin accessibilityShereen Ezzat, Shunjiang Yu, Sylvia L Asa
The American Journal of Pathology|August 26, 2003
Ikaros isoforms in human pituitary tumors: distinct localization, histone acetylation, and activation of the 5' fibroblast growth factor receptor-4 promoterShereen Ezzat, Shunjiang Yu, Sylvia L Asa
American Journal of Physiology. Endocrinology and Metabolism|August 10, 2002
Fibroblast growth factor receptor 4 (FGFR4) mediates signaling to the prolactin but not the FGFR4 promoterShunjiang Yu, Lei Zheng, Sylvia L Asa, et al.
The Journal of Biological Chemistry|March 19, 2003
Pituitary tumor AP-2alpha recognizes a cryptic promoter in intron 4 of fibroblast growth factor receptor 4ShunJiang Yu, Sylvia L Asa, Ronald J Weigel, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 7, 2004
Distinct transcriptional control and action of fibroblast growth factor receptor 4 in differentiating skeletal muscle cellsShunjiang Yu, Lei Zheng, Denny K Trinh, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 10, 2006
An essential role for the hematopoietic transcription factor Ikaros in hypothalamic-pituitary-mediated somatic growthShereen Ezzat, Rene Mader, Sandra Fischer, et al.
The Journal of Clinical Investigation|April 21, 2005
Ikaros integrates endocrine and immune system developmentShereen Ezzat, Rene Mader, ShunJiang Yu, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|April 17, 2024
A randomized, double-blind, placebo-controlled, phase IIa, clinical study on investigating the efficacy and safety of SPH3127 tablet in patients with essential hypertensionFang Wang, Ling Liu, Hongyun Ruan, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Molecular Endocrinology (Baltimore, Md.)|May 1, 2002
Fibroblast growth factor receptor 4 is a target for the zinc-finger transcription factor Ikaros in the pituitaryShunJiang Yu, Sylvia L Asa, Shereen Ezzat
Molecular Endocrinology (Baltimore, Md.)|December 25, 2004
The zinc finger Ikaros transcription factor regulates pituitary growth hormone and prolactin gene expression through distinct effects on chromatin accessibilityShereen Ezzat, Shunjiang Yu, Sylvia L Asa
The American Journal of Pathology|August 26, 2003
Ikaros isoforms in human pituitary tumors: distinct localization, histone acetylation, and activation of the 5' fibroblast growth factor receptor-4 promoterShereen Ezzat, Shunjiang Yu, Sylvia L Asa
American Journal of Physiology. Endocrinology and Metabolism|August 10, 2002
Fibroblast growth factor receptor 4 (FGFR4) mediates signaling to the prolactin but not the FGFR4 promoterShunjiang Yu, Lei Zheng, Sylvia L Asa, et al.
The Journal of Biological Chemistry|March 19, 2003
Pituitary tumor AP-2alpha recognizes a cryptic promoter in intron 4 of fibroblast growth factor receptor 4ShunJiang Yu, Sylvia L Asa, Ronald J Weigel, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 7, 2004
Distinct transcriptional control and action of fibroblast growth factor receptor 4 in differentiating skeletal muscle cellsShunjiang Yu, Lei Zheng, Denny K Trinh, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 10, 2006
An essential role for the hematopoietic transcription factor Ikaros in hypothalamic-pituitary-mediated somatic growthShereen Ezzat, Rene Mader, Sandra Fischer, et al.
The Journal of Clinical Investigation|April 21, 2005
Ikaros integrates endocrine and immune system developmentShereen Ezzat, Rene Mader, ShunJiang Yu, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|April 17, 2024
A randomized, double-blind, placebo-controlled, phase IIa, clinical study on investigating the efficacy and safety of SPH3127 tablet in patients with essential hypertensionFang Wang, Ling Liu, Hongyun Ruan, et al.
Pageof 1